PRESS RELEASE
News
-
-
PRESS RELEASE
Bioversys reports corporate highlights and key financials for the first half 2025
BioVersys AG reports key financials and corporate highlights for the first half of 2025, including successful Phase 2 outcomes: BV100 Phase 3 on track, Alpibectir Phase 2 with GSK, BV500 collaboration with Shionogi, improved FY 2025 guidance -
REGULATED PRESS RELEASE
Museum Studio entre en discussions exclusives en vue d’acquérir, exploiter et développer mondialement Chaplin’s World
Museum Studio envisage d'acquérir et développer mondialement Chaplin’s World, célébrant l'univers de Charlie Chaplin. Diversification et rayonnement international prévus -
REGULATED PRESS RELEASE
Museum Studio enters exclusive discussions to acquire, operate and develop Chaplin’s World internationally
Museum Studio in exclusive talks to acquire and expand Chaplin's World internationally, celebrating the cinematic universe of Charlie Chaplin. Acquisition to enhance cultural offerings globally -
REGULATED PRESS RELEASE
TINC publiceert een sterk tussentijds resultaat en ligt op schema om haar portefeuille te verdubbelen na de volledige investering van de opbrengst van de recente kapitaalverhoging
TINC verdubbelt portefeuille na sterke investeringen en kapitaalverhoging, met focus op infrastructuurbedrijven en rendement. Tussentijds resultaat toont groei en waarde-creatie voor aandeelhouders -
REGULATED PRESS RELEASE
TINC publishes strong interim results and is well on track to double its investment portfolio with the proceeds of the recent rights issue fully invested
TINC doubles investment portfolio with strong interim results and strategic growth, distributing €0.59 per share to shareholders. Total cash receipts €46.4M -
REGULATED PRESS RELEASE
TINC publishes strong interim results and is well on track to double its investment portfolio with the proceeds of the recent rights issue fully invested
TINC reports strong interim results, fully investing recent rights issue proceeds to double investment portfolio. Shareholders' equity grows to €615.3 million -
-
-
